| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |